DAVID FITZMAURICE: Open Payments
NPI 1194834259 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,977 in 180 payments from 22 companies in 2025. Trend: 2023 $3,387 · 2024 $4,514 · 2025 $4,977
Food & beverage: $4,869Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $1,030 |
| Janssen Biotech, Inc. | 27 | $576 |
| UCB, Inc. | 15 | $551 |
| Galderma Laboratories, L.P. | 3 | $324 |
| Novartis Pharmaceuticals Corporation | 15 | $316 |
| GENZYME CORPORATION | 10 | $300 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $300 |
| Botanix SB Inc | 10 | $267 |
| LEO Pharma Inc. | 14 | $264 |
| Regeneron Healthcare Solutions, Inc. | 7 | $189 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, BOTOX, NEMLUVIO, RINVOQ, ILUMYA.
Industry payments across FL — which companies pay providers there.
